Category Archives: consumer health apps

Behavior Change Driving Digital Health is Bubbling Up from the Bottom

Posted on April 5, 2016 by admin

This week marks one month since ePharma Summit 2016 opened and closed. It’s a good time to reflect on a final takeaway from the conference and close my notebook. Clearly, there is more grand thinking about the future and emphasis … Continue reading →

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health IT, health policy, health reform, healthcare change management, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | 1 Comment

Healthcare Industry: World’s Largest Hairball?

Posted on March 23, 2016 by admin

Insight from WEGO CEO Jack Barrette and REVOLUTION CEO Steve Case Epharma Summit 2016 has been over for two weeks, but the ideas generated by exciting thinkers, disruptors and innovators are still burning holes in my notebook. Upon reflection, themes … Continue reading →

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing | 2 Comments

Talking Past Each Other: Patient Engagement is More Than a Slogan

Posted on March 8, 2016 by admin

By Peggy Salvatore This is one of a series of blogs posted out of the ePharma Summit 2016 where pharmaceutical marketing folks talked tech for three days. The future is here. We just need to recognize it and start using … Continue reading →

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales, training | Leave a comment

Digital Health Holds the Promise of Serving the “Underserved”

Posted on February 23, 2016 by admin

By Peggy Salvatore This is the eighth entry in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. A report put out by the California Health Care Foundation  last week … Continue reading →

Posted in consumer health apps, elearning, electronic patient records, health economics, health insurance, health IT, health IT training, health policy, health reform, healthcare change management, healthcare marketing | 1 Comment

Why Digital Health Is About Survival

Posted on February 16, 2016 by admin

This is the seventh entry in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. Whether it is data collection in the electronic patient record, information in the claims data … Continue reading →

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health reform, healthcare change management, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment

Money Changes Everything Edition of Health Wonk Review

Posted on February 13, 2016 by admin

Steve Anderson is seeing green at MedicareResources.org this week for his compilation of health wonkery. Read this week’s Money Changes Everything edition here.

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health IT training, health policy, health reform, healthcare change management, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment

Oh, The Problems Connectivity Can Solve!

Posted on February 7, 2016 by admin

  This is the sixth entry in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. How many times have you heard the term “silo” in reference to your organization? … Continue reading →

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare change management, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment

Health Wonk Review 10th Anniversary Edition!

Posted on January 29, 2016 by admin

    Reposted from Joe Paduda, Managed Care Matters Well, that didn’t take very long… Hard as it is to believe, Health Wonk Review has been around for a decade.  Yup, since way back in the DSL days, before the birth … Continue reading →

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment

Why a Ban on Rx DTC Advertising Makes Me Uncomfortable

Posted on January 24, 2016 by admin

And why digital health will eventually make the ban irrelevant By Peggy Salvatore This is the fourth in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. I vaguely … Continue reading →

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment

Meaningful Use Demise Opens Door to Truly Meaningful Health Tech Advances

Posted on January 19, 2016 by admin

By Peggy Salvatore MBA   This is the third in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. Ding. Dong. MU is dead. The pivot by CMS … Continue reading →

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare change management, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment